Institutional investors hold a majority ownership of ISIS through the 91.07% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2014, these large investors purchased a net $2.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EAGLE ASSET MANAGEMENT, INC. Bought 1.3 Million shares of Isis Pharmaceuticals Inc
ALTRINSIC GLOBAL ADVISORS LLC Bought 939.0 Thousand shares of Isis Pharmaceuticals Inc